Pardis Mokhtary
Pardis Mokhtary was born and educated in Iran. She trained in medical laboratory technologies and graduated in 2014. She worked in a medical laboratory between 2014 to 2016 and gained vast experience in diagnostic techniques for Vibrio chlolerae, Mycobacterium tuberculosis, E. coli, HIV. She obtained her Master in Medical Biotechnologies in 2018 at the Golestan University of Medical Sciences, Gorgan, Iran. Her master project dealt with “Cationic vesicles for efficient shRNA transfection in the MCF-7 breast cancer cell line (MDA-MB-231 cell, PBMC cell)” and was supervised and managed by Dr. Vahid Erfani Moghadam. The results of her work were published in the International Journal of Nanomedicine. Pardis joined the MAD-Lab team in August 2020 and will be working on the discovery and development of human monoclonal antibodies against anti-microbial